{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"E10 E04: Pfizer\u2019s Richard Maughan on the future of access in the UK","description":"This week, the team is joined by Richard Maughan, Senior Director and Head of UK Policy and Public Affairs, Pfizer, to explore how the UK is shaping access to medicine today, and what needs to change in the future. From healthy ageing to the economic cost of respiratory infections, they dive into what the UK is getting right, where it\u2019s falling short and why access to medicine matters now more than ever. A little more on EMJ GOLD\u2019s guest\u2026 Richard is Senior Director and Head of UK Policy and Public Affairs at Pfizer. His team works with public policymakers to deliver breakthroughs that change patients\u2019 lives, spanning Pfizer\u2019s broad medicines and vaccines portfolio, and deep science footprint. He is a member of Pfizer\u2019s UK Senior Leadership Team and Europe Policy & Public Affairs Leadership Team. Prior to Pfizer, Richard was Head of UK Government Affairs for Eli Lilly and Company. He has also worked at the Confederation of British Industry (CBI), the UK\u2019s leading business lobbying group. He studied Politics at the University of Edinburgh and the University of California Santa Cruz, and grew up in north-east England. ","author_name":"EMJ GOLD: Pharma news, views and analysis","author_url":"http:\/\/emgpodcast1.libsyn.com\/website","html":"